β-Catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 816-820

  Wang, Zheng ^a   Ma, Qingyong ^a  

^a First Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL NUCLEUS; GENE EXPRESSION; GENE THERAPY; METASTASIS; MORBIDITY; MORTALITY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

BETA CATENIN; CHEMOKINES, CXC; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RECEPTOR CROSS-TALK; RECEPTORS, CXCR4;

EID: 34547830895     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.069     Document Type: Article

References (37)

1. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 6 (2003) 453-458
2. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
3. Wu X.Z., Chen D., and Xie G.R. Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?. Med Hypotheses 66 6 (2006) 1115-1120
4. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 4 7 (2004) 540-550
5. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13 (2006) 191-199
6. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 5 (2006) 1761-1767
7. Tamamura H., Tsutsumi H., Fujii N., et al. The chemokine receptor CXCR4 as a therapeutic target for several diseases. Mini Rev Med Chem 6 9 (2006) 989-995
8. Kucia M., Jankowski K., Reca R., et al. CXCR4-SDF-1 signaling, locomotion, chemotaxis and adhesion. J Mol Histol 35 3 (2004) 233-245
9. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 6824 (2001) 50-56
10. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14 3 (2004) 171-179
11. Luker K.E., and Luker G.D. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238 1 (2006) 30-41
12. Hatse S., Princen K., Bridger G., De Clercq E., and Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527 1-3 (2002) 255-262
13. Juarez J., Bendall L., and Bradstock K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des 10 11 (2004) 1245-1259
14. Ottaiano A., di Palma A., Napolitano M., et al. Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother 54 8 (2005) 781-791
15. Wehler T., Wolfert F., Schimanski C.C., et al. Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep 16 6 (2006) 1159-1164
16. Saur D., Seidler B., Schneider G., et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129 4 (2005) 1237-1250
17. Marchesi F., Monti P., Leone B.E., et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64 22 (2004) 8420-8427
18. Mori T., Doi R., Koizumi M., et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3 1 (2004) 29-37
19. Brand S., Dambacher J., Beigel F., et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310 1 (2005) 117-130
20. Zagzag D., Krishnamachary B., Yee H., et al. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65 14 (2005) 6178-6188
21. Vila-Coro A.J., Rodriguez-Frade J.M., Martin De Ana A., Moreno-Ortiz M.C., Martinez A.C., and Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J 13 13 (1999) 1699-1710
22. Kukreja P., Abdel-Mageed A.B., Mondal D., Liu K., and Agrawal K.C. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 65 21 (2005) 9891-9898
23. Wang J., Wang J., Sun Y., et al. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17 12 (2005) 1578-1592
24. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 5663 (2004) 1483-1487
25. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127 3 (2006) 469-480
26. Harris T.J., and Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol 15 5 (2005) 234-237
27. Giarre M., Semenov M.V., and Brown A.M. Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types. Ann N Y Acad Sci 857 (1998) 43-55
28. Brabletz T., Hlubek F., Spaderna S., et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179 1-2 (2005) 56-65
29. Han S.A., Chun H., Park C.M., et al. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Clin Oncol (R Coll Radiol) 18 10 (2006) 761-767
30. Yang F., Zeng Q., Yu G., Li S., and Wang C.Y. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18 5 (2006) 679-687
31. Pujal J., Capella G., and Real F.X. The Wnt pathway is active in a small subset of pancreas cancer cell lines. Biochim Biophys Acta 1762 1 (2006) 73-79
32. Lee H.S., Park M.H., Yang S.J., et al. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci (2006)
33. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 1 (2003) 1-24
34. Apte U., Zeng G., Muller P., et al. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44 4 (2006) 992-1002
35. Nawshad A., Lagamba D., Polad A., and Hay E.D. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179 1-2 (2005) 11-23
36. Barker N., and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5 12 (2006) 997-1014
37. Luo Y., Cai J., Xue H., Mattson M.P., and Rao M.S. SDF1alpha/CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 398 3 (2006) 291-295